在结核性硬化综合症中治疗发作时,Cenobamate的有效性
Gewalin Aungaroon1, Alexander Cooke2, David Ritter1
1Division of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Division of Pediatrics, University of Cincinnati, Cincinnati, Ohio.
Pediatric neurology
|October 19, 2024
概括
巴 (CBM) 在结核性硬化综合体 (TSC) 患者中显示出发作减少,但反应率低于预期. 耐受CBM和管理并发药物的挑战需要进一步调查,以改善治疗保留.
科学领域:
- 神经学 神经学
- 发病学 (Epileptology) 是一个专业的学科.
- 药理学 药理学是指药理学的学科.
背景情况:
- 在结核性硬化综合体 (TSC) 中的管理存在重大挑战.
- 在TSC患者中,塞诺巴酸盐 (CBM) 的疗效在很大程度上仍未被描述.
研究的目的:
- 评估结核性硬化综合体 (TSC) 患者辅助赛诺巴酸盐 (CBM) 的疗效和耐受性.
主要方法:
- 对54名接受辅助CBM治疗的TSC患者的回顾性审查.
- 发作频率在基线和3,6,12和18个月的随访期间进行了比较.
- 评估了治疗持续时间,反应率和副作用.
主要成果:
- 在64.8%的患者中观察到显著的发作减少,平均减少61.5%至74.6%.
- 在18个月内,响应率 (≥50%的发作减少) 从38.1%到59.1%不等.
- 常见的副作用包括镇静 (42.6%) 和行为障碍 (24.1%),影响治疗的持续时间.
结论:
- 辅助CBM可以在TSC患者中减少发作,但与一般患者相比,响应率和无发作率较低.
- 在TSC和CBM耐受性问题中独特的发可能有助于这些发现.
- 优化并发药物调整至关重要,以改善这一群体的治疗保留率.
相关概念视频
Antiepileptic Drugs: Potassium Channel Activators
147
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
147
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
258
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
258
Antiepileptic Drugs: GABAergic Pathway Potentiators
336
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
336
Antiepileptic Drugs: Sodium Channel Blockers
437
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
437
Electroconvulsive Therapy
25
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
25
Antiepileptic Drugs: Calcium Channel Blockers
330
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
330


